Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB S Sanlioglu, CM Williams, L Samavati, NS Butler, G Wang, PB McCray, ... Journal of Biological Chemistry 276 (32), 30188-30198, 2001 | 502 | 2001 |
Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation S Sanlioglu, PK Benson, J Yang, EM Atkinson, T Reynolds, JF Engelhardt Journal of virology 74 (19), 9184-9196, 2000 | 419 | 2000 |
Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning … L Shen, LC Wu, S Sanlioglu, R Chen, AR Mendoza, AW Dangel, ... Journal of Biological Chemistry 269 (11), 8466-8476, 1994 | 234 | 1994 |
Incretins: their physiology and application in the treatment of diabetes mellitus HM Tasyurek, HA Altunbas, MK Balci, S Sanlioglu Diabetes/metabolism research and reviews 30 (5), 354-371, 2014 | 174 | 2014 |
Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells AD Sanlioglu, E Dirice, C Aydin, N Erin, S Koksoy, S Sanlioglu BMC cancer 5, 1-17, 2005 | 164 | 2005 |
Mitochondrial KATP channel openers activate the ERK kinase by an oxidant-dependent mechanism L Samavati, MM Monick, S Sanlioglu, GR Buettner, LW Oberley, ... American Journal of Physiology-Cell Physiology 283 (1), C273-C281, 2002 | 150 | 2002 |
Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression D Duan, P Sharma, L Dudus, Y Zhang, S Sanlioglu, Z Yan, Y Yue, Y Ye, ... Journal of virology 73 (1), 161-169, 1999 | 124 | 1999 |
Rate limiting steps of AAV transduction and implications for human gene therapy S Sanlioglu, MM Monick, G Luleci, GW Hunninghake, JF Engelhardt Current gene therapy 1 (2), 137-147, 2001 | 122 | 2001 |
GPx-1 Gene Delivery Modulates NFκB Activation Following Diverse Environmental Injuries Through a Specific Subunit of the IKK Complex Q Li, S Sanlioglu, S Li, T Ritchie, L Oberley, JF Engelhardt Antioxidants and Redox Signaling 3 (3), 415-432, 2001 | 111 | 2001 |
Ectopic overexpression of engrailed-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions SL Baader, S Sanlioglu, AS Berrebi, J Parker-Thornburg, J Oberdick Journal of Neuroscience 18 (5), 1763-1773, 1998 | 95 | 1998 |
Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction S Sanlioglu, D Duan, JF Engelhardt Human Gene Therapy 10 (4), 591-602, 1999 | 90 | 1999 |
Clinical utility of insulin and insulin analogs AD Sanlioglu, HA Altunbas, MK Balci, TS Griffith, S Sanlioglu Islets 5 (2), 67-78, 2013 | 80 | 2013 |
Inhibition of the NF-κB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells B Karacay, S Sanlioglu, TS Griffith, A Sandler, DJ Bonthius Cancer Gene Therapy 11 (10), 681-690, 2004 | 78 | 2004 |
Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation S Sanlioglu, P Benson, JF Engelhardt Virology 268 (1), 68-78, 2000 | 78 | 2000 |
Selective disruption of “late onset” sagittal banding patterns by ectopic expression of engrailed-2 in cerebellar Purkinje cells SL Baader, MW Vogel, S Sanlioglu, X Zhang, J Oberdick Journal of Neuroscience 19 (13), 5370-5379, 1999 | 76 | 1999 |
The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma IT Koksal, E Dirice, D Yasar, AD Sanlioglu, A Ciftcioglu, KH Gulkesen, ... Urologic Oncology: Seminars and Original Investigations 22 (4), 307-312, 2004 | 70 | 2004 |
Genetic redox preconditioning differentially modulates AP-1 and NFκB responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis J Yang, JJ Marden, C Fan, S Sanlioglu, RM Weiss, TC Ritchie, ... Molecular Therapy 7 (3), 341-353, 2003 | 70 | 2003 |
DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells AD Sanlioglu, B Karacay, IT Koksal, TS Griffith, S Sanlioglu Cancer gene therapy 14 (12), 976-984, 2007 | 66 | 2007 |
TRAIL Death Receptor–4 Expression Positively Correlates With the Tumor Grade in Breast Cancer Patients With Invasive Ductal Carcinoma AD Sanlioglu, AF Korcum, E Pestereli, G Erdogan, S Karaveli, B Savas, ... International Journal of Radiation Oncology* Biology* Physics 69 (3), 716-723, 2007 | 66 | 2007 |
Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways S Sanlioglu, JF Engelhardt Gene therapy 6 (8), 1427-1437, 1999 | 62 | 1999 |